Nuwellis (NUWE)
(Delayed Data from NSDQ)
$1.42 USD
+0.07 (5.19%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $1.40 -0.02 (-1.41%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for Nuwellis, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 9 | 8 | 7 | 6 |
Cost Of Goods | 4 | 4 | 3 | 3 | 3 |
Gross Profit | 5 | 5 | 4 | 4 | 3 |
Selling & Adminstrative & Depr. & Amort Expenses | 23 | 22 | 24 | 21 | 21 |
Income After Depreciation & Amortization | -18 | -17 | -20 | -17 | -18 |
Non-Operating Income | 1 | 12 | 0 | 1 | 0 |
Interest Expense | 3 | 9 | 0 | 0 | 0 |
Pretax Income | -20 | -15 | -20 | -16 | -18 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -20 | -15 | -20 | -16 | -18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -20 | -15 | -20 | -16 | -18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -17 | -17 | -19 | -17 | -18 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -18 | -17 | -20 | -17 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.06 | 0.01 | 0.00 | 0.00 | NA |
Diluted EPS Before Non-Recurring Items | -402.80 | -2,921.33 | NA | NA | NA |
Diluted Net EPS (GAAP) | -402.80 | -2,921.33 | NA | NA | -9.30 |
Fiscal Year end for Nuwellis, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2.19 | 1.86 | 2.55 | 2.41 | 2.08 |
Cost Of Goods | 0.72 | 0.67 | 1.16 | 1.03 | 0.93 |
Gross Profit | 1.47 | 1.19 | 1.39 | 1.38 | 1.15 |
SG&A, R&D, and Dept/Amort Expenses | 3.80 | 5.94 | 4.98 | 4.55 | 6.17 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.33 | -4.75 | -3.59 | -3.17 | -5.02 |
Non-Operating Income | 0.20 | 0.42 | 1.57 | -0.20 | 0.18 |
Interest Expense | 5.61 | 0.00 | 3.48 | 0.00 | 0.00 |
Pretax Income | -7.72 | -4.33 | -5.51 | -3.37 | -4.84 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.73 | -4.33 | -5.51 | -3.37 | -4.85 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.73 | -4.33 | -5.51 | -3.37 | -4.85 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 0.41 | 0.18 | 0.10 | 0.05 | 0.04 |
Diluted EPS Before Non-Recurring Items | -18.85 | -20.98 | -78.32 | -63.29 | -127.62 |
Diluted Net EPS (GAAP) | -18.85 | -20.98 | -10.49 | -63.29 | -127.62 |